Management of acute coronary syndromes in Mexico: Gaps and opportunities to improve outcomes

American Journal of Cardiovascular Drugs

Volumn 9, Issue 3, 2009, Pages 143-148

  Leiva Pons, Jose L ^a  

^a HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MEXICO; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; DRUG COSTS; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEXICO; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 66849097995     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03256571     Document Type: Review

References (33)

1. Cannon CP. Acute coronary syndromes: risk stratification and initial management. Cardiol Clin 2005 Nov; 23 (4): 401-9, v
2. Smith SW, Whitwam W. Acute coronary syndromes. Emerg Med Clin North Am 2006 Feb; 24 (1): 53-89, vi
3. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007 Aug 14; 116 (7): e148-304
4. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee. Circulation 2008 Jan 15; 117 (2): 296-329
5. Fox KAA, Anderson Jr FA, Goodman SG, et al. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry. Nat Clin Pract Cardiovasc Med 2008 Sep; 5 (9): 580-9
6. Goldberg RJ, Currie K, White K, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004 Feb 1; 93 (3): 288-93
7. Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006 Nov 25; 333 (7578): 1091
8. Chavez Dominguez R, Ramirez Hernandez JA, Casanova Garces JM. [Coronary heart disease in Mexico and the clinical epidemiological and preventive relevance]. Arch Cardiol Mex 2003 Apr-Jun; 73 (2): 105-14
9. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007 May 2; 297 (17): 1892-900
10. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with athero-thrombosis. JAMA 2006 Jan 11; 295 (2): 180-9
11. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 Mar 21; 297 (11): 1197-206
12. Lupi-Herrera E. [Mexican Cardiology Society Guidelines on the management of patients with unstable angina and non-ST-segment elevation myo-cardial infarction. Cancun, Quintana Roo 15-16 November 2002. Cooperative Group of Consensus]. Arch Cardiol Mex 2002 Oct-Dec; 72 Suppl. 2: S5-44
13. Garcia-Castillo A, Sanchez-Dias CJ, Martinez Sanchez C, et al. Clinical guidelines for the management of ST segment elevation myocardial infarction. Mexican Society of Cardiology and National Association of Mexican Cardiologists Working Group]. Arch Cardiol Mex 2006; 76 Suppl. 3: 12-120
14. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006 Apr 26; 295 (16): 1912-20
15. Lupi Herrera E. [National Registry of Acute Ischemic Coronary Syndromes (RENASICA). Mexican Cardiology Society. The RENASICA Cooperative Group]. Arch Cardiol Mex 2002 Oct-Dec; 72 Suppl. 2: S45-64
16. Garcia-Castillo A, Jerjes-Sanchez C, Martinez Bermudez P, et al. Mexican Registry of Acute Coronary Syndromes. Arch Cardiol Mex 2005 Jan-Mar; 75 Suppl. 1: S6-32
17. Cohen MG, Pacchiana CM, Corbalan R, et al. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Am Heart J 2001 Mar; 141 (3): 391-401
18. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) projects in Michigan. J Am Coll Cardiol 2005 Oct 4; 46 (7): 1242-8
19. Gottwik M, Zahn R, Schiele R, et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J 2001 Oct; 22 (19): 1794-801
20. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006 Oct; 27 (19): 2285-93
21. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006 Apr 6; 354 (14): 1464-76
22. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myo-cardial infarction: the OASIS-6 randomized trial. JAMA 2006 Apr 5;295 (13): 1519-30
23. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006 Nov 23; 355 (21): 2203-16
24. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006 Apr 6; 354 (14): 1477-88
25. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 Aug 16; 345 (7): 494-502
26. Grines CL, Bonow RO, Casey Jr DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007 Feb 13; 115 (6): 813-8
27. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005 Nov 5; 366 (9497): 1607-21
28. Moser DK, Kimble LP, Alberts MJ, et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation 2006 Jul 11; 114 (2): 168-82
29. de la Llata M, Gaspar J, Ferez S, et al. [Results of the Census of Hemodynamic Services and Interventional Cardiology 2000 in the Mexican Republic]. Arch Cardiol Mex 2001 Oct-Dec; 71 (4): 347-56
30. Gaspar HJ, Guadalajara Boo JF,de laLlata RomeroM.[Heart catheterization in Mexico: results of the 1996 census of heart catheterization services bythe Mexican Society of Cardiology]. Arch Inst Cardiol Mex 1996 Sep-Oct; 66 (5): 449-54
31. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001 Aug 18; 358 (9281): 527-33
32. Sabatine MS, Cannon CP, Gibson CM, etal. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005 Mar 24; 352 (12): 1179-89
33. Sabatine MS, Cannon CP, Gibson CM, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005 Sep 14; 294 (10): 1224-32